Teacher Retirement System of Texas trimmed its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,201 shares of the basic materials company's stock after selling 11,269 shares during the period. Teacher Retirement System of Texas owned 0.10% of Balchem worth $5,086,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of BCPC. Watts Gwilliam & Co. LLC lifted its position in shares of Balchem by 63.7% in the fourth quarter. Watts Gwilliam & Co. LLC now owns 35,069 shares of the basic materials company's stock valued at $5,438,000 after acquiring an additional 13,642 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Balchem by 1.7% during the third quarter. JPMorgan Chase & Co. now owns 458,986 shares of the basic materials company's stock worth $80,782,000 after buying an additional 7,721 shares in the last quarter. Stifel Financial Corp raised its position in shares of Balchem by 26.2% in the third quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company's stock valued at $2,093,000 after buying an additional 2,467 shares during the last quarter. Apollon Wealth Management LLC purchased a new stake in Balchem during the 4th quarter valued at about $503,000. Finally, Congress Asset Management Co. raised its holdings in Balchem by 5.4% in the 4th quarter. Congress Asset Management Co. now owns 317,610 shares of the basic materials company's stock valued at $51,769,000 after acquiring an additional 16,170 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.
Balchem Trading Up 0.6 %
BCPC traded up $0.91 on Thursday, hitting $166.11. The company had a trading volume of 112,863 shares, compared to its average volume of 114,953. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The firm has a market cap of $5.40 billion, a P/E ratio of 42.27, a PEG ratio of 4.41 and a beta of 0.63. The company's fifty day moving average price is $165.07 and its 200 day moving average price is $169.28. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03.
Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to analysts' expectations of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. As a group, equities analysts expect that Balchem Co. will post 4.64 earnings per share for the current year.
Wall Street Analysts Forecast Growth
BCPC has been the subject of a number of recent research reports. Sidoti raised Balchem to a "hold" rating in a research note on Tuesday, February 25th. HC Wainwright reissued a "buy" rating and issued a $190.00 price target on shares of Balchem in a research note on Monday, February 24th. Finally, StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research report on Tuesday, February 25th.
Read Our Latest Report on Balchem
About Balchem
(
Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Articles

Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.